241 related articles for article (PubMed ID: 31376032)
1. Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT.
Marsh RA; Leiding JW; Logan BR; Griffith LM; Arnold DE; Haddad E; Falcone EL; Yin Z; Patel K; Arbuckle E; Bleesing JJ; Sullivan KE; Heimall J; Burroughs LM; Skoda-Smith S; Chandrakasan S; Yu LC; Oshrine BR; Cuvelier GDE; Thakar MS; Chen K; Teira P; Shenoy S; Phelan R; Forbes LR; Chellapandian D; Dávila Saldaña BJ; Shah AJ; Weinacht KG; Joshi A; Boulad F; Quigg TC; Dvorak CC; Grossman D; Torgerson T; Graham P; Prasad V; Knutsen A; Chong H; Miller H; de la Morena MT; DeSantes K; Cowan MJ; Notarangelo LD; Kohn DB; Stenger E; Pai SY; Routes JM; Puck JM; Kapoor N; Pulsipher MA; Malech HL; Parikh S; Kang EM;
J Clin Immunol; 2019 Oct; 39(7):653-667. PubMed ID: 31376032
[TBL] [Abstract][Full Text] [Related]
2. Allogeneic hematopoietic cell transplantation is effective for p47phox chronic granulomatous disease: A Primary Immune Deficiency Treatment Consortium study.
Grunebaum E; Arnold DE; Logan B; Parikh S; Marsh RA; Griffith LM; Mallhi K; Chellapandian D; Lim SS; Deal CL; Kapoor N; Murguía-Favela L; Falcone EL; Prasad VK; Touzot F; Bleesing JJ; Chandrakasan S; Heimall JR; Bednarski JJ; Broglie LA; Chong HJ; Kapadia M; Prockop S; Dávila Saldaña BJ; Schaefer E; Bauchat AL; Teira P; Chandra S; Parta M; Cowan MJ; Dvorak CC; Haddad E; Kohn DB; Notarangelo LD; Pai SY; Puck JM; Pulsipher MA; Torgerson TR; Malech HL; Kang EM; Leiding JW
J Allergy Clin Immunol; 2024 May; 153(5):1423-1431.e2. PubMed ID: 38290608
[TBL] [Abstract][Full Text] [Related]
3. Hematopoietic Cell Transplantation for Chronic Granulomatous Disease in Japan.
Yanagimachi M; Kato K; Iguchi A; Sasaki K; Kiyotani C; Koh K; Koike T; Sano H; Shigemura T; Muramatsu H; Okada K; Inoue M; Tabuchi K; Nishimura T; Mizukami T; Nunoi H; Imai K; Kobayashi M; Morio T
Front Immunol; 2020; 11():1617. PubMed ID: 32849547
[TBL] [Abstract][Full Text] [Related]
4. Role of Allogeneic Hematopoietic Stem Cell Transplant for Chronic Granulomatous Disease (CGD): a Report of the United States Immunodeficiency Network.
Yonkof JR; Gupta A; Fu P; Garabedian E; Dalal J;
J Clin Immunol; 2019 May; 39(4):448-458. PubMed ID: 31111420
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic Hematopoietic Cell Transplantation in Patients with Primary Immunodeficiencies in Korea: Eleven-Year Experience in a Single Center.
Yi ES; Choi YB; Lee NH; Lee JW; Sung KW; Koo HH; Kang ES; Kim YJ; Yoo KH
J Clin Immunol; 2018 Oct; 38(7):757-766. PubMed ID: 30151618
[TBL] [Abstract][Full Text] [Related]
6. Effect of allogeneic hematopoietic stem cell transplantation for chronic granulomatous disease in children: A multicentre, retrospective cohort study in China.
Si Y; Dou Y; Zhai X; Zhou C; Lu W; Meng Y; Qian X; Chen J; Wang P; Luo C; Yu J; Tang X
Clin Immunol; 2024 Mar; 260():109919. PubMed ID: 38309448
[TBL] [Abstract][Full Text] [Related]
7. Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGD.
Leiding JW; Arnold DE; Parikh S; Logan B; Marsh RA; Griffith LM; Wu R; Kidd S; Mallhi K; Chellapandian D; Si Lim SJ; Grunebaum E; Falcone EL; Murguia-Favela L; Grossman D; Prasad VK; Heimall JR; Touzot F; Burroughs LM; Bleesing J; Kapoor N; Dara J; Williams O; Kapadia M; Oshrine BR; Bednarski JJ; Rayes A; Chong H; Cuvelier GDE; Forbes Satter LR; Martinez C; Vander Lugt MT; Yu LC; Chandrakasan S; Joshi A; Prockop SE; Dávila Saldaña BJ; Aquino V; Broglie LA; Ebens CL; Madden LM; DeSantes K; Milner J; Rangarajan HG; Shah AJ; Gillio AP; Knutsen AP; Miller HK; Moore TB; Graham P; Bauchat A; Bunin NJ; Teira P; Petrovic A; Chandra S; Abdel-Azim H; Dorsey MJ; Birbrayer O; Cowan MJ; Dvorak CC; Haddad E; Kohn DB; Notarangelo LD; Pai SY; Puck JM; Pulsipher MA; Torgerson TR; Malech HL; Kang EM
Blood; 2023 Dec; 142(24):2105-2118. PubMed ID: 37562003
[TBL] [Abstract][Full Text] [Related]
8. Influence of Previous Inflammatory Bowel Disease on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation: A Matched-Pair Analysis.
Rabian F; Porcher R; Sicre de Fontbrune F; Lioure B; Laplace A; Nguyen S; Tabrizi R; Vigouroux S; Tomowiak C; Maillard N; Suarez F; Delage J; Peffault de Latour R; Socié G;
Biol Blood Marrow Transplant; 2016 Sep; 22(9):1721-1724. PubMed ID: 27246370
[TBL] [Abstract][Full Text] [Related]
9. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
10. Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study.
Güngör T; Teira P; Slatter M; Stussi G; Stepensky P; Moshous D; Vermont C; Ahmad I; Shaw PJ; Telles da Cunha JM; Schlegel PG; Hough R; Fasth A; Kentouche K; Gruhn B; Fernandes JF; Lachance S; Bredius R; Resnick IB; Belohradsky BH; Gennery A; Fischer A; Gaspar HB; Schanz U; Seger R; Rentsch K; Veys P; Haddad E; Albert MH; Hassan M;
Lancet; 2014 Feb; 383(9915):436-48. PubMed ID: 24161820
[TBL] [Abstract][Full Text] [Related]
11. Experience with a Reduced Toxicity Allogeneic Transplant Regimen for Non-CGD Primary Immune Deficiencies Requiring Myeloablation.
Chandra S; Chandrakasan S; Dávila Saldaña BJ; Bleesing JJ; Jordan MB; Kumar AR; Grimley MS; Krupski C; Davies SM; Khandelwal P; Marsh RA
J Clin Immunol; 2021 Jan; 41(1):89-98. PubMed ID: 33067658
[TBL] [Abstract][Full Text] [Related]
12. Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience.
Morillo-Gutierrez B; Beier R; Rao K; Burroughs L; Schulz A; Ewins AM; Gibson B; Sedlacek P; Krol L; Strahm B; Zaidman I; Kalwak K; Talano JA; Woolfrey A; Fraser C; Meyts I; Müller I; Wachowiak J; Bernardo ME; Veys P; Sykora KW; Gennery AR; Slatter M
Blood; 2016 Jul; 128(3):440-8. PubMed ID: 27216217
[TBL] [Abstract][Full Text] [Related]
13. Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft.
Horwitz ME; Barrett AJ; Brown MR; Carter CS; Childs R; Gallin JI; Holland SM; Linton GF; Miller JA; Leitman SF; Read EJ; Malech HL
N Engl J Med; 2001 Mar; 344(12):881-8. PubMed ID: 11259721
[TBL] [Abstract][Full Text] [Related]
14. Hematopoietic cell transplantation in chronic granulomatous disease: a study of 712 children and adults.
Chiesa R; Wang J; Blok HJ; Hazelaar S; Neven B; Moshous D; Schulz A; Hoenig M; Hauck F; Al Seraihy A; Gozdzik J; Ljungman P; Lindemans CA; Fernandes JF; Kalwak K; Strahm B; Schanz U; Sedlacek P; Sykora KW; Aksoylar S; Locatelli F; Stepensky P; Wynn R; Lum SH; Zecca M; Porta F; Taskinen M; Gibson B; Matthes S; Karakukcu M; Hauri-Hohl M; Veys P; Gennery AR; Lucchini G; Felber M; Albert MH; Balashov D; Lankester A; Güngör T; Slatter MA
Blood; 2020 Sep; 136(10):1201-1211. PubMed ID: 32614953
[TBL] [Abstract][Full Text] [Related]
15. Hematopoietic stem cell transplantation in children with chronic granulomatous disease: the Spanish experience.
Alonso García L; Bueno Sánchez D; Fernández Navarro JM; Regueiro Garcia A; Blanquer Blanquer M; Benitez Carabante MI; Mozo Del Castillo Y; Fuster Soler JL; Uria Oficialdegui ML; Sisinni L; Perez Martinez A; Diaz de Heredia Rubio C
Front Immunol; 2024; 15():1307932. PubMed ID: 38370416
[TBL] [Abstract][Full Text] [Related]
16. A phase 2 trial of the somatostatin analog pasireotide to prevent GI toxicity and acute GVHD in allogeneic hematopoietic stem cell transplant.
Ramalingam S; Siamakpour-Reihani S; Bohannan L; Ren Y; Sibley A; Sheng J; Ma L; Nixon AB; Lyu J; Parker DC; Bain J; Muehlbauer M; Ilkayeva O; Kraus VB; Huebner JL; Spitzer T; Brown J; Peled JU; van den Brink M; Gomes A; Choi T; Gasparetto C; Horwitz M; Long G; Lopez R; Rizzieri D; Sarantopoulos S; Chao N; Sung AD
PLoS One; 2021; 16(6):e0252995. PubMed ID: 34170918
[TBL] [Abstract][Full Text] [Related]
17. Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation.
El-Jawahri A; Chen YB; Brazauskas R; He N; Lee SJ; Knight JM; Majhail N; Buchbinder D; Schears RM; Wirk BM; Wood WA; Ahmed I; Aljurf M; Szer J; Beattie SM; Battiwalla M; Dandoy C; Diaz MA; D'Souza A; Freytes CO; Gajewski J; Gergis U; Hashmi SK; Jakubowski A; Kamble RT; Kindwall-Keller T; Lazarus HM; Malone AK; Marks DI; Meehan K; Savani BN; Olsson RF; Rizzieri D; Steinberg A; Speckhart D; Szwajcer D; Schoemans H; Seo S; Ustun C; Atsuta Y; Dalal J; Sales-Bonfim C; Khera N; Hahn T; Saber W
Cancer; 2017 May; 123(10):1828-1838. PubMed ID: 28102896
[TBL] [Abstract][Full Text] [Related]
18. Healthcare resource utilization and costs associated with acute graft-versus-host disease following allogeneic hematopoietic cell transplantation.
Yu J; Lal L; Anderson A; DuCharme M; Parasuraman S; Weisdorf D
Support Care Cancer; 2020 Nov; 28(11):5491-5499. PubMed ID: 32172407
[TBL] [Abstract][Full Text] [Related]
19. Failure to Prevent Severe Graft-Versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide in Chronic Granulomatous Disease.
Parta M; Hilligoss D; Kelly C; Kwatemaa N; Theobald N; Zerbe CS; Holland SM; Malech HL; Kang EM
J Clin Immunol; 2020 May; 40(4):619-624. PubMed ID: 32314173
[TBL] [Abstract][Full Text] [Related]
20. Infectious Risk after Allogeneic Hematopoietic Cell Transplantation Complicated by Acute Graft-versus-Host Disease.
Miller HK; Braun TM; Stillwell T; Harris AC; Choi S; Connelly J; Couriel D; Goldstein S; Kitko CL; Magenau J; Pawarode A; Reddy P; Riwes M; Yanik GA; Levine JE
Biol Blood Marrow Transplant; 2017 Mar; 23(3):522-528. PubMed ID: 28017733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
